Morning Roundup: Mar. 8, 2019

Japan uses facial recognition to tackle gambling addiction, FDA commissioner to resign, musicians in recovery reach thousands with song ‘Sober.’

Essay: The ‘I Do’ of Addiction [New Yorker]
An excerpt from the personal history of Mitchell S. Jackson. “If selling dope to my mama was what it had come to, I knew for absolute certain it would have to come to an end for me.”

Japan To Use Facial Recognition to Restrict Admission of Gambling Addicts [Japan Times]
Facial recognition technology is part of a plan to help certain folks stay out of gambling venues. Under a new plan to combat gambling addiction, gambling “addicts” or their family may request that the government help keep them away from temptation. 

Which Misused Prescription Meds Send Americans to the ER? [US News]
The majority of drug poisonings in a new study were caused by the use of multiple substances. Researchers unveil findings from a review of emergency room data involving prescription drug misuse in 2016.

FDA Commissioner Dr. Scott Gottlieb To Resign Next Month [CNN]
Dr. Scott Gottlieb, the commissioner of the U.S. Food an Drug Administration, has announced his resignation. He is leaving to spend more time with his family, he says. 

Two ‘Sober’ Musicians’ Message of Addiction Is Reaching Thousands [Hartford Courant]
Through music, two people in recovery were able to craft a powerful message with their song “Sober.” The single has hit home for a lot of people who have had similar experiences. 

Red Wings Broadcaster Hopes Eye-Opening Addiction Message Gets People Talking [Hometown Life]
Detroit Red Wings broadcaster Ken Daniels is sharing the story of losing his 23-year-old son to a fatal opioid overdose. “There is a stigma about talking about issues from the neck, up. That has got to stop.” 

Nebraska Puts Brakes on Drug Testing Parents in Child Abuse Cases [KETV]
Parents suspected of neglect or abuse will no longer be drug tested in Nebraska. Meanwhile, the debate on whether drug testing is necessary in such cases continues.

What Makes the Ketamine-Based Drug for Depression So Different? [Live Science]
This week, the FDA approved the first ketamine-based drug for depression treatment. Live Science explains how this treatment differs from traditional antidepressants.

View the original article at thefix.com

Fri, March 8, 2019| The Fix|In Addiction News

or

Privacy Preference Center